AMPA receptor potentiators

Details for Australian Patent Application No. 2007333247 (hide)

Owner Eli Lilly and Company

Inventors Dominguez-Manzanares, Esteban

Agent Spruson & Ferguson

Pub. Number AU-B-2007333247

PCT Pub. Number WO2008/073789

Priority 60/888,562 07.02.07 US; 06380319.1 11.12.06 EP

Filing date 6 December 2007

Wipo publication date 19 June 2008

Acceptance publication date 7 June 2012

International Classifications

C07C 311/06 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/073789 Priority application(s): WO2008/073789

7 June 2012 Application Accepted

  Published as AU-B-2007333247

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333249-Coated cannula with protective tip for insertion into a patient

2007333243-Phosphoinositide 3-kinase inhibitor compounds and methods of use